![Andreas Scheuerle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andreas Scheuerle
Chief Executive Officer at Blisterzentrum Baden-Württemberg GmbH
Profile
Andreas Scheuerle is currently the Managing Director at Blisterzentrum Baden-Württemberg GmbH and an Economist at Dekabank Deutsche Girozentrale (Research).
He previously worked as an Economist at Deka Investment GmbH.
Andreas Scheuerle active positions
Companies | Position | Start |
---|---|---|
Dekabank Deutsche Girozentrale (Research) | Economist | - |
Blisterzentrum Baden-Württemberg GmbH
![]() Blisterzentrum Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Part of Medios AG, Blisterzentrum Baden-Württemberg GmbH is a pharmaceutical company based in Magstadt, Germany. Blisterzentrum Baden-Württemberg GmbH provides important information on data protection and current events and appointments through their contact number. The CEO of the German company is Andreas Scheuerle. Blisterzentrum Baden-Württemberg GmbH was acquired by Medios AG on January 01, 2023 for $30.72 million. | Chief Executive Officer | - |
Former positions of Andreas Scheuerle
Companies | Position | End |
---|---|---|
Deka Investment GmbH
![]() Deka Investment GmbH Investment ManagersFinance Deka Investment GmbH (Deka) is the wholly-owned asset management subsidiary of DekaBank Deutsche Girozentrale in Germany. Founded in 1995, the firm is headquartered in Frankfurt and acts as the investment arm of the DekaBank Group. The firm offers a range of funds in a variety of asset classes including large-, mid- and small-cap, corporate and government bonds, asset backed securities and convertible bonds for retail and institutional investors. | Analyst-Equity | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Deka Investment GmbH
![]() Deka Investment GmbH Investment ManagersFinance Deka Investment GmbH (Deka) is the wholly-owned asset management subsidiary of DekaBank Deutsche Girozentrale in Germany. Founded in 1995, the firm is headquartered in Frankfurt and acts as the investment arm of the DekaBank Group. The firm offers a range of funds in a variety of asset classes including large-, mid- and small-cap, corporate and government bonds, asset backed securities and convertible bonds for retail and institutional investors. | Finance |
Dekabank Deutsche Girozentrale (Research) | Finance |
Blisterzentrum Baden-Württemberg GmbH
![]() Blisterzentrum Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Part of Medios AG, Blisterzentrum Baden-Württemberg GmbH is a pharmaceutical company based in Magstadt, Germany. Blisterzentrum Baden-Württemberg GmbH provides important information on data protection and current events and appointments through their contact number. The CEO of the German company is Andreas Scheuerle. Blisterzentrum Baden-Württemberg GmbH was acquired by Medios AG on January 01, 2023 for $30.72 million. | Health Technology |
- Stock Market
- Insiders
- Andreas Scheuerle